INTEGRAL DIAGNOSTICS LIMITED (ASX: IDX)
Health care · News and insights
Price unavailable
Latest IDX announcements
Announcement Insights
Integral Diagnostics’ FY26 Growth Meets Workforce Constraints
Integral Diagnostics’ FY26 revenue rose 26% to $789 million and operating profit increased 30% to $165 million, but limited access to radiologists and sonographers constrained its ability to meet demand. The company said strategic and operational changes are planned for FY27; the update reported no new earnings guidance.
Updated 06 Nov 2026, 07:49 AM Sydney time
Sources
Change of Director's Interest Notice - Andy Fay NEDCorrection to App3Y - Andy Fay NEDChange of Director's Interest Notice - Jason Martinez CEOChange in substantial holdingChange of Director's Interest Notice - Dr Kevin Shaw NEDAGM - Chair & CEO PresentationsResults of Annual General MeetingComments
2026-11-04 · Health care
IDX: $1.71 -2.85% · MC: $622M
Integral Diagnostics corrected its director-interest notice, confirming Andrew Fay indirectly acquired 60,000 shares through his spouse, bringing her reported holding to 107,000 shares. The correction replaces the original notice’s erroneous prior holding; Fay’s direct and superannuation-trust holdings were unchanged.
Updated 2026-11-04 17:30
Sources
Change of Director's Interest Notice - Andy Fay NEDCorrection to App3Y - Andy Fay NEDComments
2026-11-02 · Health care
IDX: $1.76 -0.28% · MC: $622M
Tribeca Investment Partners’ reported voting power in Integral Diagnostics rose from 5.03% to 6.04%, while CEO Jason Martinez acquired additional shares on market, increasing his direct holding from 30,000 to 45,000 shares. The substantial-holder notice lists on-market purchases and sales since its previous filing, but the supplied excerpt does not include the full transaction schedule.
Updated 2026-11-02 17:37
Sources
Change of Director's Interest Notice - Jason Martinez CEOChange in substantial holdingComments
2026-10-30 · Health care
IDX: $1.76 -0.56% · MC: $622M
Integral Diagnostics director Kevin Shaw disclosed an on-market purchase of shares through an account held jointly with Dr Jane Jie Li; the notice reports no change to the disclosed holdings before and after the transaction. The announcement gives the transaction date as November 30, 2026, which is after its October 30 publication date.
Updated 2026-10-30 14:32
Sources
Change of Director's Interest Notice - Dr Kevin Shaw NEDComments
2026-10-29 · Health care
IDX: $1.77 -14.66% · MC: $622M
Integral Diagnostics shareholders passed all resolutions at its annual general meeting, including the re-election of directors Toby Hall and Ingrid Player and grants of performance rights. In the chair’s address, the company said shortages of radiologists and sonographers continued to constrain its ability to meet demand. The board said management planned strategic and operational changes in the current financial year intended to deliver benefits in future years.
Updated 2026-10-29 15:29
Sources
AGM - Chair & CEO PresentationsResults of Annual General MeetingComments
Comments